Northern Trust’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$255K Sell
120,741
-49,486
-29% -$104K ﹤0.01% 3856
2025
Q1
$208K Sell
170,227
-74,047
-30% -$90.3K ﹤0.01% 3933
2024
Q4
$315K Buy
244,274
+9,994
+4% +$12.9K ﹤0.01% 3832
2024
Q3
$644K Buy
234,280
+107,306
+85% +$295K ﹤0.01% 3503
2024
Q2
$287K Buy
126,974
+25,823
+26% +$58.4K ﹤0.01% 3722
2024
Q1
$242K Buy
101,151
+129
+0.1% +$308 ﹤0.01% 3831
2023
Q4
$168K Sell
101,022
-942
-0.9% -$1.56K ﹤0.01% 3955
2023
Q3
$196K Hold
101,964
﹤0.01% 3819
2023
Q2
$147K Buy
101,964
+7,206
+8% +$10.4K ﹤0.01% 3933
2023
Q1
$199K Buy
94,758
+9,895
+12% +$20.8K ﹤0.01% 3861
2022
Q4
$95.9K Sell
84,863
-390
-0.5% -$441 ﹤0.01% 4102
2022
Q3
$139K Sell
85,253
-4,608
-5% -$7.51K ﹤0.01% 4013
2022
Q2
$118K Sell
89,861
-3,677
-4% -$4.83K ﹤0.01% 4103
2022
Q1
$150K Sell
93,538
-450
-0.5% -$722 ﹤0.01% 4226
2021
Q4
$194K Buy
93,988
+5,168
+6% +$10.7K ﹤0.01% 4207
2021
Q3
$345K Sell
88,820
-7,450
-8% -$28.9K ﹤0.01% 3911
2021
Q2
$309K Sell
96,270
-324,833
-77% -$1.04M ﹤0.01% 3922
2021
Q1
$913K Sell
421,103
-31,854
-7% -$69.1K ﹤0.01% 3620
2020
Q4
$1.01M Sell
452,957
-13,007
-3% -$29.1K ﹤0.01% 3512
2020
Q3
$1.25M Sell
465,964
-28,385
-6% -$75.8K ﹤0.01% 3297
2020
Q2
$1.51M Sell
494,349
-22,685
-4% -$69.4K ﹤0.01% 3185
2020
Q1
$1.01M Buy
517,034
+26,722
+5% +$52.4K ﹤0.01% 3212
2019
Q4
$1.4M Buy
490,312
+874
+0.2% +$2.5K ﹤0.01% 3287
2019
Q3
$1.8M Buy
489,438
+355,322
+265% +$1.3M ﹤0.01% 3155
2019
Q2
$556K Buy
134,116
+44,345
+49% +$184K ﹤0.01% 3528
2019
Q1
$458K Buy
89,771
+2,839
+3% +$14.5K ﹤0.01% 3559
2018
Q4
$298K Sell
86,932
-953
-1% -$3.27K ﹤0.01% 3675
2018
Q3
$529K Buy
87,885
+1,267
+1% +$7.63K ﹤0.01% 3621
2018
Q2
$551K Buy
86,618
+7,362
+9% +$46.8K ﹤0.01% 3579
2018
Q1
$376K Sell
79,256
-4,412
-5% -$20.9K ﹤0.01% 3641
2017
Q4
$279K Buy
83,668
+2,929
+4% +$9.77K ﹤0.01% 3706
2017
Q3
$173K Buy
80,739
+5,642
+8% +$12.1K ﹤0.01% 3833
2017
Q2
$185K Buy
75,097
+3,176
+4% +$7.82K ﹤0.01% 3817
2017
Q1
$165K Buy
71,921
+26,716
+59% +$61.3K ﹤0.01% 3840
2016
Q4
$44K Buy
45,205
+1,978
+5% +$1.93K ﹤0.01% 4021
2016
Q3
$49K Hold
43,227
﹤0.01% 4003
2016
Q2
$63K Buy
43,227
+4,250
+11% +$6.19K ﹤0.01% 3980
2016
Q1
$56K Sell
38,977
-3,995
-9% -$5.74K ﹤0.01% 4004
2015
Q4
$71K Sell
42,972
-21,650
-34% -$35.8K ﹤0.01% 3998
2015
Q3
$151K Sell
64,622
-117,855
-65% -$275K ﹤0.01% 3826
2015
Q2
$498K Sell
182,477
-21,787
-11% -$59.5K ﹤0.01% 3565
2015
Q1
$684K Buy
204,264
+433
+0.2% +$1.45K ﹤0.01% 3530
2014
Q4
$707K Sell
203,831
-2,563
-1% -$8.89K ﹤0.01% 3471
2014
Q3
$1.04M Buy
206,394
+142,337
+222% +$716K ﹤0.01% 3407
2014
Q2
$885K Buy
64,057
+23,815
+59% +$329K ﹤0.01% 3440
2014
Q1
$616K Buy
40,242
+4,825
+14% +$73.9K ﹤0.01% 3499
2013
Q4
$286K Buy
35,417
+3,302
+10% +$26.7K ﹤0.01% 3630
2013
Q3
$320K Buy
+32,115
New +$320K ﹤0.01% 3537